Publication:
SERUM ENDOSTATIN LEVEL IS ASSOCIATED WITH POOR SURVIVAL IN PATIENTS WITH ADVANCED STAGES OF HEPATOCELLULAR CARCINOMA

dc.contributor.authorsYegin, E.; Syikymbayev, A.; Ozdogan, O. C.
dc.date.accessioned2022-03-12T16:14:08Z
dc.date.accessioned2026-01-11T17:31:34Z
dc.date.available2022-03-12T16:14:08Z
dc.date.issued2013
dc.identifier.doi10.1016/S0168-8278(13)60667-4
dc.identifier.issn0168-8278
dc.identifier.urihttps://hdl.handle.net/11424/225246
dc.identifier.wosWOS:000322983000666
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.relation.ispartofJOURNAL OF HEPATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.titleSERUM ENDOSTATIN LEVEL IS ASSOCIATED WITH POOR SURVIVAL IN PATIENTS WITH ADVANCED STAGES OF HEPATOCELLULAR CARCINOMA
dc.typeconferenceObject
dspace.entity.typePublication
oaire.citation.endPageS270
oaire.citation.startPageS270
oaire.citation.titleJOURNAL OF HEPATOLOGY
oaire.citation.volume58

Files